MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Clinical characteristics of scan without evidence of dopaminergic deficits (SWEDDs) in Japan.

    M. Takahashi, Y. Tashiro, N. Ito, T. Sato, T. Sekiguchi, A. Inaba, S. Orimo (Tokyo, Japan)

    Objective: To examine the clinical characteristics of SWEDDs and to compare to that of Parkinson’s disease (PD). Background: Patients with SWEDDs are defined as clinically…
  • 2017 International Congress

    Brain PET metabolic substrate of Impulse Control Disorders in Parkinson’s Disease

    E. Robin, A. Verger, F. Fluchere, T. Witjas, J.P. Azulay, E. Guedj, A. Eusebio (Marseille, France)

    Objective: The aim of this study was to describe the cerebral metabolic PET substrate and related connectivity changes in Parkinson's disease patients with impulse control…
  • 2017 International Congress

    Longitudinal Cortical Thickness Changes in GBA-Positive Relative to GBA-negative Parkinson’s Disease Patients with Hemiparkinsonism

    I. Stankovic, N. Kresojevic, F. Agosta, V. Markovic, E. Sarasso, P. Valsasina, I. Petrovic, M. Filippi, V. Kostic (Belgrade, Serbia)

    Objective: This study investigated the longitudinal changes of the cortical grey matter in Parkinson’s disease (PD) patients with hemiparkinsonism, with (GBA-positive) and without (GBA-negative) glucocerebrosidase…
  • 2017 International Congress

    Cognitive changes and cortical thinning evolution of parkinson’s disease patients: 4-year-follow up.

    A. Campabadal, C. Uribe, B. Segura, H. Baggio, A. Abos, A. Garcia-Diaz, M.-J. Marti, Y. Compta, F. Valldeoriola, C. Junque (Barcelona, Spain)

    Objective: The aim of the study was to investigate differences in the progression of cognitive decline and cortical thinning evolution in Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease

    M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We evaluated the signal intensity of the cerebral gyri (CG) on phase difference enhanced imaging (PADRE) for the patients with corticobasal degeneration (CBD), progressive…
  • 2017 International Congress

    EEG Shows Subclinical Motor Preparation Deficits in Parkinson’s Disease Patients with Freezing of Gait During Locomotion

    C. Fearon, J. Butler, S. Waechter, I. Killane, L. Newman, T. Munteanu, D. Birsanu, B. Magennis, R. Reilly, T. Lynch (Dublin 7, Ireland)

    Objective: Investigate motor preparation and cognition in Parkinson’s disease (PD) patients with and without freezing of gait (FOG) while sitting and stepping with EEG. Background:…
  • 2017 International Congress

    Connectivity patterns in frontal cognitive regions in Parkinson’s disease

    A. Hanganu, A. Nagano-Saito, A. Tam, N. Auclair-Ouellet, S. Jobert, B. Mejia-Constain, D. Schoemaker, C. Degroot, A.-L. Lafontaine, H. Chertkow, P. Bellec, O. Monchi (Calgary, AB, Canada)

    Objective: Evaluate the changes in brain connectivity between Parkinson’s disease (PD) with and without mild cognitive impairment (MCI). Background: Up to 40% of PD patients…
  • 2017 International Congress

    Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease

    M. Gilat, P. Bell, K. Ehgoetz Martens, M. Georgiades, J. Hall, C. Walton, S. Lewis, J. Shine (Sydney, Australia)

    Objective: Investigating the role of dopaminergic medication on the neural mechanisms underlying lower limb motor automaticity during fMRI in 23 patients with PD that were…
  • 2017 International Congress

    Altered Resting-State Functional Interhemispheric Connectivity in Parkinson’s Disease

    X. Dan, S. Lin, A. Liu, J. Wang, T. Wu, P. Chan, M. McKeown (Beijing, China)

    Objective: To examine direct interhemispheric functional connectivity (FCi) in Parkinson's disease (PD) during resting-state fMRI and to investigate the relations between observed connectivity changes and…
  • 2017 International Congress

    Dopamine Normalizes Putamen to Insula Activation Shift During Choice Reaction Time Task in PD

    J. Kim, K. Zhang, S. YorkWilliams, M. Ua Cruadhlaoich, V. Menon, K. Poston (Palo Alto, CA, USA)

    Objective: We investigated Parkinson’s disease (PD) patients during a functional MRI Choice Reaction Time (CRT) task and determined whether brain activations are altered by dopamine. Background:…
  • « Previous Page
  • 1
  • …
  • 1520
  • 1521
  • 1522
  • 1523
  • 1524
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley